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The European PARTNER project developed a prototypical system for sharing hadron therapy data. This
system allows doctors and patients to record and report treatment-related events during and after hadron
therapy. It presents doctors and statisticians with an integrated view of adverse events across institutions,
using open-source components for data federation, semantics, and analysis. There is a particular emphasis
upon semantic consistency, achieved through intelligent, annotated form designs. The system as presented
is ready for use in a clinical setting, and amenable to further customization. The essential contribution of
the work reported here lies in the novel data integration and reporting methods, as well as the approach to
software sustainability achieved through the use of community-supported open-source components.
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INTRODUCTION
There is a need for increased data sharing in cancer care and
cancer research [1, 2]. In the case of hadron therapy, this
need is particularly pronounced. Also known as particle or
ion beam therapy, it involves the innovative use of protons
and carbon ions [3], and while this promises significant
advantages, more information is required to support adop-
tion, to determine suitability, and to support treatment plan-
ning. Furthermore, there are relatively few treatment centres,
and patients often cross national boundaries for treatment.
There is a requirement for effective follow-up to compare
outcomes and establish efficacy [4], and a European initia-
tive has been established to provide this [5, 6].
An analysis of the hadron therapy domain, considering the
requirement for data interoperability and the achievements of
existing eHealth initiatives, has informed the design of a
‘Hadron therapy Information Sharing Prototype’ (HISP), as a
gateway to patient information held in multiple hospital data-
bases and a means of supporting patient follow-up in multi-
centre clinical studies [7, 8].
To demonstrate the functionality of the system, we focus
on an adverse-event-reporting scenario—a key component
of comprehensive patient follow-up. The reporting of
adverse, treatment-related events is part of the patient man-
agement process, beginning with the initial visit where a
baseline is assessed, continuing during treatment with each
clinical review, and then at intervals during follow-up. This
demonstration covers the main aspects of system functional-
ity: patients and doctors report an adverse event as struc-
tured, coded information; this information is integrated into
medical records at treatment centres, and is then available,
across a distributed architecture, under role-based access
control.
The prototype was developed within the PARTNER
Project, as a collaborative effort between three Marie-Curie
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Early Stage Researchers and four institutions: CERN, IFIC,
the University of Oxford, and the University of Surrey [5].
This paper reports upon the design of the architecture and
principal components, as well as upon the benefits and lim-
itations of the existing implementation.
MATERIALS AND METHODS
The system provides a single access point for patient infor-
mation distributed across multiple hospital databases. At
the design level, it can be seen as a generic server infra-
structure, with services for data integration and presenta-
tion, and other services for reporting and analysis.
System architecture
The particular challenges within this domain include (i) a
lack of interoperability between existing clinical care
systems; (ii) the distribution of information pertaining to an
individual patient across multiple systems; and (iii) a lack
of consistent and amenable policies for data access. These
challenges had a profound influence upon the system
design, the data model, and the development process.
The architectural design was based upon the storyline or
pathway of an individual patient undergoing hadron therapy
[9]. In this storyline, data is collected in two countries,
from different actors: doctors and patient. Data is held
within local networks, but made available to external ser-
vices. The prototypical infrastructure was realized on four
servers distributed across two sites (Fig. 1) [10, 11]:
• CERN server 1: presentation services, user
interface
• CERN server 2: integration services
• CERN server 3: metadata and reporting services,
data capture
• IFIC server 4: database located at second site.
Databases
The hospital data repositories, Hospital or Oncology
Information Systems (HIS/OIS), export data to local HISP
databases remaining under local governance (DB1 and
DB2). The basic data model adopted for this scenario repre-
sents a ‘care summary’ view of the data, suitable for use
across institutions. Raw images, laboratory reports, and
treatment plans are not shared in this scenario. Sample data
to validate the system was generated from published clinical
trials, and imported into the hospital databases for testing
purposes.
The model [12] comprises four tables of data: patient in-
formation (e.g. demographics, history); tumour information
(e.g. type, staging); treatment information (e.g. dose and
beam quality); and adverse-events information (e.g. scoring
system, adverse event, grade, time of onset). The data in the
first three tables would be imported automatically from hos-
pital systems; only the adverse-events data needs to be
acquired separately. The structure of the model allows for the
submission of patient- and doctor-reported event information
to different data standards. In the example schema, however,
any reported event has to be represented as a combination of
‘adverse-event name’, ‘severity score’ and ‘scoring system’.
For the inclusion of patient-reported outcome measures, this
would require an initial transformation step in the reporting
services, anticipated in the architecture design.
One part of the generated patient data was stored in the
IFIC ‘MySQL’ server (DB1); the other was stored in a CERN
‘Oracle’ database instance (DB2) [13, 14]. As ‘Oracle’ data-
bases, often used in hospital environments, have different
characteristics to ‘MySQL’ databases (operations, schema and
access), this allowed us to test low-level interoperability and
integration functions.
Data integration
The architecture relies upon ‘data federation’ to provide an
integrated view across heterogeneous data sources, present-
ing their aggregation as a virtual database. This virtual data-
base does not contain the data itself, but instead holds
information about the data locations, types, and access pro-
cedures. The data remains within the source organisations,
which are able to determine the extent to which it may be
accessed across the system.
‘JBoss Teiid’ was used as the federation platform [15],
hosted on CERN server 2, and used to integrate the two data-
bases, ‘MySQL’ and ‘Oracle’, to produce a virtual database
(VDB) view. The view was restricted to address the particu-
lar requirements of the adverse-event-reporting scenario [10].
Portal
The user interface for the system was based upon the
‘Liferay portal’, an enterprise-level, open-source standards-
compliant web platform [16]. The medical domain has
Fig. 1. HISP architecture: data stored in DB1 and DB2 is held
locally but available remotely.
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particular requirements for standards, certification, and
support; this technology addressed these, while providing a
range of useful, packaged functionality. For the interface, we
used ‘Openxava’: a ‘Java’-based framework for the rapid
development of internet applications [17], compatible with
‘Liferay’. The combined framework allowed us to produce
interfaces that were both easy to use and easy to develop.
Security
Three primary roles are defined for authorization (doctor,
patient, researcher), together with two further, secondary
roles (new user and administrator) [10]. ‘Doctor’ is the
most privileged role, affording access to all patient data
within the federation. ‘Researcher’ allows a simple statistic-
al analysis. ‘Patient’ affords access to the follow-up forms.
A given user can be assigned multiple roles, depending
upon the context of current activity.
Communication with the HISP portal (server) is secured
using the Transport Layer Security (TLS) version 1.2 en-
cryption protocol. Users can login via password-based au-
thentication or public key certificates loaded into the client
browser: the second approach, suitable for use within a con-
trolled hospital environment, facilitates access and provides
increased security overall [18].
Data reporting
The data reporting functionality was designed for web-
based structured reporting of medical findings, with
minimum standards of documentation, facilitating the
re-use of data across contexts.
Metadata services
To facilitate re-use, the intended meaning of the data must
be documented and be available as ‘metadata’ in a comput-
able form. Metadata registries serve as common reference
points for metadata standards, and provide services for
metadata registration, curation and versioning. ISO/IEC
11179 is a standard for metadata registries, addressing ‘the
semantics of data, the representation of data, and the regis-
tration of the descriptions of that data’ to promote common
understanding, harmonization, and re-use [19]. A key part
of this standard is the notion of a common data element, a
fundamental unit of metadata that may be applied to data
collected or managed in a different context. A data element
is intended to provide a full description of the meaning of a
given observation. To provide the required metadata
support for the adverse-event scenario, we used the
‘CancerGrid’ metadata registry (cgMDR) [20], an open-
source implementation of the ISO/IEC 11179 standard.
Data reporting services
The reporting services had to be widely accessible: to
provide verification of data entry prior to submission, and
to allow for changes in requirements to be easily
accommodated through the versioning of data-capture
instruments and data schemas. This latter aspect is particu-
larly important for early-phase clinical studies, where the
set of observations to be made is not finalized at the outset
of the study. It is important also in the context of new or
evolving reporting instruments and standards, e.g. where
new measures are being devised for the reporting of ‘sub-
jective’ adverse events after therapy.
The ‘Extensible Markup Language’ (XML) [21] was
chosen as the serialization format for submitted data,
reflecting a flexible document-centric approach in which
every form submission corresponds to a single observation
record. The validity of any submitted record can be verified
using an XML schema. By annotating the schema files
with SAWSDL references [22] pointing to the respective
data elements registered in the metadata registry, collected
data is prepared for future data-integration scenarios.
Data-reporting forms were developed in ‘XForms’ [23],
an XML-based standard recommended by the World Wide
Web Consortium (W3C) for the declarative definition of
web forms. We used ‘betterFORMS’, a server-side imple-
mentation of XForms [24], to make the forms accessible
using standard web technologies. Validation rules within
the form specification are used to check data prior to
storage in a native XML database: ‘eXist-db’ [25], was
chosen for this purpose.
The identity of the submitter (patient or doctor and re-
spective credentials), the subject (patient and credentials),
and the associated treatment centre is verified at form sub-
mission. A user-defined extract of the reported data, pos-
sibly involving data transformations to comply with the
target schema, is then transmitted into the local database
(DB1 or DB2 in Fig. 1) and becomes available to federated
queries. In the prototype implementation, this functionality
is provided by a ‘ModPython’ [26] script, retrieving the
submitted XML record, performing the necessary data
transformations, and generating the query statements to
insert the data into the database.
All of the above services are hosted on CERN server 3.
Data-reporting forms were created for patient-reported
outcome measures, based on existing questionnaires [27].
Forms were created for the submission of adverse-event
reports, based on reporting standards such as CTCAE,
RTOG and SomaLent [28–31].
Analysis service
The federated data can be used to provide a range of
analysis services. Depending upon the user’s role, these
can be customized to address specific needs. We used PHP
and the Google charts API [32] to build a simple
proof-of-concept report. This queries the VDB anonymous-
ly to produce statistical information about the cumulated
adverse events: for example, a piechart display of the total
numbers of the five most common adverse events. A range
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of parameters for the queries can be selected using drop-
down menus.
RESULTS
The HISP PARTNER prototype system demonstrates a par-
ticular approach to the acquisition and re-use of relevant
medical data. The following features are seen as benefits or
advantages of the approach:
• the ability to query data across a federation of het-
erogeneous database systems
• the availability of an easy-to-use portal interface
with role-based access control
• the use of semantic web and metadata technologies
to facilitate semantic annotation of data
• the support for versioning of patient-reported
outcome and objective adverse-event measures.
DISCUSSION
Although existing solutions for clinical data management—
such as OpenClinica [33], caAERS [34], or the particle
database system developed within the European ULICE-
framework [35]—provide functionalities that the HISP
prototype does not support, the system serves well to dem-
onstrate a range of different and important features.
Rather than employing a traditional ‘data warehousing’
approach [35], HISP relies on ‘data federation’ to provide
an integrated view across heterogeneous data sources.
A warehousing approach requires a fixed model, less amen-
able to change, and could lead to concerns over data
control and privacy. This was a particularly important con-
sideration given the evolving nature of the science and
medical practice, as well as the concrete specification of
governance constraints upon medical data (typically, ‘the
data stays within the hospital; only suitably abstracted ver-
sions of the data may be made available externally, and
then only for clearly specified purposes’).
Where reporting scenarios involve multiple institutions,
and where data collection may take place over a period of
years, clear documentation of reporting intent is needed
for subsequent, correct interpretation and re-use. As the
scale of data collection increases, the importance of
machine-readable documentation—computable metadata—
increases also. The advantages of semantic annotation
based upon metadata standards have also been demon-
strated in [36]. An important feature of the HISP design is
that annotation is part of the form design process, ensuring
that data is associated, automatically, with a computable
representation of its meaning at the point of collection.
A model-driven approach is used to automate the process
of form implementation, minimizing the development effort
involved [37], improving quality, and reducing the cost of
validation [38]. Other reporting systems frequently provide
the means of facilitating the form design process by provid-
ing ‘form builders’: some of these are simplistic [39];
others treat each form as an indivisible whole [33, 40], pre-
venting comparison and re-use at a data-element or ques-
tion level. As different conditions, different questions, and
even different individuals may be presented with different
forms [41], the ability to compare designs at a question
level is essential for data re-use and integration. The ability
to re-use designs at this level is equally essential for the
harmonization of reporting standards and procedures.
Lessons learned from the prototype development have
informed the design of comprehensive metamodel, or
domain-specific language, for form specification [42].
The use of open-source components is incidental to the
design of the system, but makes an important contribution
to its extensibility and potential for adoption. The purpose
of the prototype is to establish technical feasibility, and sig-
nificant extension would be required for wider deployment
outside the context of the originating project: for example,
a collection of standard interfaces to hospital databases and
messaging systems. However, the system as it stands serves
as a complete demonstration for the proposed approach, as
well as a platform for further development.
ACKNOWLEDGEMENTS
The authors are grateful to Prof. B. Jones (Gray Inst.,
PTCRi) and Prof. R. Mayer (EBG MedAustron GmbH), as
well as the hospitals of Oxford and Valencia for discus-
sions regarding all medical aspects of the project. This
project would not have been possible without the assistance
of M. Cirilli, A. Di Girolamo, H.F. Hoffmann and
A. Valassi (CERN). Further, the authors would like to
thank the CERN IT-ES group, as well as S. Harris and
C. Crichton (University of Oxford, PTCRi) for technical
support and numerous valuable discussions.
FUNDING
This work was supported by a Marie Curie Initial Training
Fellowship of the European Community’s Seventh Framework
Programme under contract number [PITN-GA-2008-215840-
PARTNER].
REFERENCES
1. Sommer J. The delay in sharing research data is costing lives.
Nat Med 2010;16:744.
2. Pisani E, AbouZahr C. Sharing health data: good intentions
are not enough. Bull World Health Organ 2010;88:462–66.
3. Wilson RR. Radiological use of fast protons. Radiology
1946;47:487–91.
Hadron therapy information sharing prototype i59
4. Lodge M, Pijls-Johannesma M, Stirk L et al. A systematic lit-
erature review of the clinical and cost-effectiveness of hadron
therapy in cancer. Radiother Oncol 2007;83:110–22.
5. Particle Training Network for European Radiotherapy
(PARTNER) Project, FP7 Grant agreement no. 215840-2.
http://cern.ch/partner (10 December 2012, date last accessed).
6. Union of Light Ion Centres in Europe (ULICE) Project,
FP7 Grant agreement no. 228436. http://cern.ch/ulice (10
December 2012, date last accessed).
7. Roman FL. Health grids: overview, added-value. PARTNER
Work Package 22—Deliverable 1. Technical report. CERN, 2009.
8. Abler D. Data integration for the PARTNER hadron therapy
information sharing platform (HISP). PARTNER Work
Package 23—Deliverable 1. Technical report. CERN, 2010.
9. Roman FL, Abler D. Services of the Hadron therapy
Information Sharing Platform. Legal and Ethical implications.
PARTNER Work Package 22 and 23 – Deliverable 2.
Technical report. CERN, 2010.
10. Roman FL. Data-driven platform for hadron therapy.
PARTNER Work Package 22 – Deliverable 3. Technical
report. CERN, 2011.
11. Abler D. Data capturing services for charged particle therapy.
PARTNER Work Package 23 – Deliverable 3. Technical
report. CERN, 2011.
12. Kanellopoulos V. A Data Model for the Follow-Up and
Evaluation of Side Effects. PARTNER Work Package 24 –
Deliverable 4. Technical report. CERN, 2010.
13. MySQL database. http://www.mysql.com/ (10 December
2012, date last accessed).
14. Oracle database. http://www.oracle.com/ (10 December 2012,
date last accessed).
15. JBoss Teiid. http://www.jboss.org/teiid/ (10 December 2012,
date last accessed).
16. Liferay Portal. http://www.liferay.com (10 December 2012,
date last accessed).
17. Openxava. http://openxava.org/web/guest (10 December
2012, date last accessed).
18. Java SE Security. http://www.oracle.com/technetwork/java/
javase/tech/index-jsp-136007.html (10 December 2012, date
last accessed).
19. ISO/IEC 11179-1: 2004(E). http://metadata-standards.org/
11179/ (10 December 2012, date last accessed).
20. CancerGrid metadata registry (cgMDR). http://www.
cancergrid.org/index.php?option=com_content&id=8:mdrarticle
(10 December 2012, date last accessed).
21. Extensible Markup Language(XML). http://www.w3.org/
XML/ (10 December 2012, date last accessed).
22. W3C Semantic Annotations for WSDL and XML Schema.
http://www.w3.org/TR/sawsdl/ (10 December 2012, date last
accessed).
23. W3C XForms 1.1. http://www.w3.org/TR/xforms11/ (10
December 2012, date last accessed).
24. betterFORM. http://www.betterform.de/en/index.html (10
December 2012, date last accessed).
25. eXist-db database. http://exist-db.org/exist/index.xml (10
December 2012, date last accessed).
26. Mod_Python. http://www.modpython.org/ (10 December
2012, date last accessed).
27. Patient reported outcome measures: head and neck radio-
therapy patient questionnaire. www.christie.nhs.uk/media/
106098/Raphnsubj.pdf (10 December 2012, date last
accessed).
28. Acute Radiation Morbidity Scoring Criteria. http://www.rtog.
org/ResearchAssociates/AdverseEventReporting/AcuteRadiation
MorbidityScoringCriteria.aspx (10 December 2012, date last
accessed).
29. RTOG/EORTC Late Radiation Morbidity Scoring Schema.
http://www.rtog.org/ResearchAssociates/AdverseEventReporting/
RTOGEORTCLateRadiationMorbidityScoringSchema.aspx (10
December 2012, date last accessed).
30. SomaLent. http://www.rtog.org/LinkClick.aspx?fileticket=_
rSiZbdkeXs%3d&tabid=140 (10 December 2012, date last
accessed).
31. Common Terminology Criteria for Adverse Events (CTCAE).
http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14.
owl (10 December 2012, date last accessed).
32. Google charts API. https://developers.google.com/chart/ (10
December 2012, date last accessed).
33. OpenClinica. https://community.openclinica.com/ (10 December
2012, date last accessed).
34. Adverse event reporting system (caAERS). http://cabig.
cancer.gov/solutions/applications/caaers/ (10 December 2012,
date last accessed).
35. Kessel KA, Bougatf N, Bohn C et al. Connection of
European particle therapy centers and generation of a
common particle database system within the European
ULICE-framework. Radiat Oncol 2012;7:115.
36. Papatheodorou I, Crichton C, Morris L et al. A metadata
approach for clinical data management in translational
genomics studies in breast cancer. BMC Med Genomics
2009;2:66.
37. Calinescu R, Harris S, Gibbons J et al. Model-driven archi-
tecture for cancer research. In: Proceedings of the 5th IEEE
International Conference on Software Engineering and
Formal Methods, London, 2007.
38. Davies J, Gibbons J, Harris S et al. Model-driven support
for a vaccine study in Kathmandu. Microsoft eScience
Workshop, 2009.
39. caBIG FormBuilder. https://cabig-stage.nci.nih.gov/community/
tools/FormBuilder (10 December 2012, date last accessed).
40. REDCap. Research Electronic Data Capture. http://
project-redcap.org/ (10 December 2012, date last accessed).
41. Richesson RL, Nadkarni P. Data standards for clinical re-
search data collection forms: current status and challenges.
JAMIA 2011;18:341–46.
42. Abler D, Crichton C, Welch J et al. Models for Forms.
Proceedings of the Compilation of the Co-located Workshops
SPLASH 2011. ACM 2011;13–18.
F.L. Roman et al.i60
